527 related articles for article (PubMed ID: 21220626)
1. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
2. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
Kellner U; Renner AB; Tillack H
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
[TBL] [Abstract][Full Text] [Related]
3. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
[TBL] [Abstract][Full Text] [Related]
4. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
Maturi RK; Yu M; Weleber RG
Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
[TBL] [Abstract][Full Text] [Related]
5. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
Lyons JS; Severns ML
Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity.
Browning DJ
Am J Ophthalmol; 2002 May; 133(5):649-56. PubMed ID: 11992862
[TBL] [Abstract][Full Text] [Related]
7. Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up.
Salu P; Uvijls A; van den Brande P; Leroy BP
Doc Ophthalmol; 2010 Jun; 120(3):251-64. PubMed ID: 20397038
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.
So SC; Hedges TR; Schuman JS; Quireza ML
Ophthalmic Surg Lasers Imaging; 2003; 34(3):251-8. PubMed ID: 12757106
[TBL] [Abstract][Full Text] [Related]
9. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
[TBL] [Abstract][Full Text] [Related]
10. Spectral-domain optical coherence tomography as a screening technique for chloroquine and hydroxychloroquine retinal toxicity.
Kahn JB; Haberman ID; Reddy S
Ophthalmic Surg Lasers Imaging; 2011; 42(6):493-7. PubMed ID: 21830746
[TBL] [Abstract][Full Text] [Related]
11. [Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses].
Rüther K; Foerster J; Berndt S; Schroeter J
Ophthalmologe; 2007 Oct; 104(10):875-9. PubMed ID: 17653725
[TBL] [Abstract][Full Text] [Related]
12. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
[TBL] [Abstract][Full Text] [Related]
13. A detailed study of the phenotype of an autosomal dominant cone-rod dystrophy (CORD7) associated with mutation in the gene for RIM1.
Michaelides M; Holder GE; Hunt DM; Fitzke FW; Bird AC; Moore AT
Br J Ophthalmol; 2005 Feb; 89(2):198-206. PubMed ID: 15665353
[TBL] [Abstract][Full Text] [Related]
14. Missing the bull's eye.
Gilbert ME; Savino PJ
Surv Ophthalmol; 2007; 52(4):440-2. PubMed ID: 17574068
[TBL] [Abstract][Full Text] [Related]
15. The multifocal pattern electroretinogram in chloroquine retinopathy.
Neubauer AS; Stiefelmeyer S; Berninger T; Arden GB; Rudolph G
Ophthalmic Res; 2004; 36(2):106-13. PubMed ID: 15017107
[TBL] [Abstract][Full Text] [Related]
16. Ocular fundus manifestation of two patients following long-term chloroquine therapy: a case report.
Ma X; Yan L; He L; He D; Lu H
Diagn Pathol; 2010 Mar; 5():20. PubMed ID: 20346186
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography in a patient with chloroquine-induced maculopathy.
Korah S; Kuriakose T
Indian J Ophthalmol; 2008; 56(6):511-3. PubMed ID: 18974527
[TBL] [Abstract][Full Text] [Related]
18. Early paracentral visual field loss in patients taking hydroxychloroquine.
Elder M; Rahman AM; McLay J
Arch Ophthalmol; 2006 Dec; 124(12):1729-33. PubMed ID: 17159032
[TBL] [Abstract][Full Text] [Related]
19. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.
Rodriguez-Padilla JA; Hedges TR; Monson B; Srinivasan V; Wojtkowski M; Reichel E; Duker JS; Schuman JS; Fujimoto JG
Arch Ophthalmol; 2007 Jun; 125(6):775-80. PubMed ID: 17562988
[TBL] [Abstract][Full Text] [Related]
20. Abnormal multifocal electroretinogram (mfERG) in ethambutol toxicity.
Kardon RH; Morrisey MC; Lee AG
Semin Ophthalmol; 2006; 21(4):215-22. PubMed ID: 17182409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
